TRYPCHI is a high-strength Trypsin–Chymotrypsin enzyme formulation designed for professional use within the orthopaedic and musculoskeletal care segment. Its positioning focuses on supporting reduction of inflammatory swelling and facilitating tissue recovery as part of a comprehensive management approach. With its convenient tablet presentation and specialist orthopaedic positioning, TRYPCHI can serve as a differentiated addition to a PCD Pharma Ortho portfolio, particularly for physicians managing trauma, soft-tissue inflammation and recovery-related concerns.
It is positioned as an enzyme-based adjunct for conditions where reduction of inflammatory swelling and support of tissue recovery are required.
It may be considered in selected orthopaedic, traumatic or post-operative situations according to clinical judgement.
No. It is generally used as part of an overall treatment plan and should not be considered a universal substitute for analgesic or anti-inflammatory therapy when those are clinically indicated.
TRYPCHI should be prescribed according to the clinical condition and overall treatment plan. The patient's history of bleeding, peptic ulceration, allergy and use of anticoagulants or antiplatelet medicines should be considered before administration. The product should be taken exactly as directed, particularly regarding timing in relation to meals when specified by the manufacturer or prescriber. Clinical response, swelling and tolerability should be reviewed rather than extending treatment unnecessarily.
Enzyme preparations are generally well tolerated, but some individuals may experience nausea, abdominal discomfort, indigestion, diarrhoea or other mild gastrointestinal symptoms. Hypersensitivity reactions such as skin rash, itching or swelling may occur in susceptible individuals. Because the formulation may influence processes related to inflammation and bleeding, particular caution is appropriate in people with bleeding disorders or those receiving medicines that affect coagulation or platelet function. Any unusual bleeding, allergic symptoms or significant gastrointestinal reaction should be assessed promptly.
TRYPCHI contains a combination of proteolytic enzymes, Trypsin and Chymotrypsin, formulated to support the body's natural inflammatory-response and tissue-recovery processes. These enzymes act on protein components associated with inflammatory tissue and may help reduce local tissue swelling and improve resolution of inflammatory changes. By supporting the breakdown and clearance of proteinaceous material at affected sites, the formulation can be positioned as an adjunct in post-traumatic, post-operative and musculoskeletal recovery where reduction of oedema and tissue discomfort is clinically desirable.
